Results

Total Results: 1,541 records

Showing results for "months".

141. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_executive.pdf
     October 01, 2006 - compared to renal artery angioplasty with stent placement on long-term clinical outcomes (at least 6 months … compared angioplasty without stent placement at the start of the trial to angioplasty delayed by 3 months … of revascularization to a variety of medical treatments for a wide range of durations–from about 6 months … Kidney function Acceptable • 2 RCTs found no difference in kidney outcomes, mostly at 6 and 12 months … Cardiovascular Weak • 1 RCT found similar rates of cardiovascular events at 3 to 54 months of followup

142. Cystic-Fibrosis-Hgh Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cystic-fibrosis-hgh_surveillance.pdf
     August 01, 2012 - , followed by 6 months followup Primary: ΔLBM, Height Std. … IGF-1: treated> controls at months 6 and 12 but not at month 18 (after 6 months off treatment) … Mortality was also associated with more hospital admissions in previous 6 months, and a 100% rate … A time period of 6-12 months may be insufficient to determine the effect of rhGH on development of … In months 6-12, females had greater height and weigh velocities than males.

143. Atrial-Fibrillation-Ablation Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/atrial-fibrillation-ablation_surveillance.pdf
     May 16, 2013 - What is the effect of radiofrequency ablation (RFA) on short- (6 to 12 months) and long- (>12 months … The length of follow-up across majority of studies was between 125,11,14 and 60 months.6 The longest … with RFA than patients treated with medical therapy reporting freedom from anticoagulation at 12 months … This study of patients with PAF found no significant difference at 12 months followup in the recurrence … AAD (n=61; dose: NR) 3 months (AAD) RFA vs.

144. Disposition of Comments Report for Breathing Exercises and/or Retraining Techniques in the Treatment of Asthma: Comparative Effectiveness (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/asthma-treatment_disposition-comments.pdf
     September 10, 2012 - Thomas, 2009, in which the follow up was 6 months rather than 4 weeks as stated), and in the numbers … , which were maintained at 12 months. … before the trial. • 1 course of prednisone given three months after the trial. 10. … • 1 course of prednisone given three months after the trial. … Results after applying Buteyko techniques for 6 months.

145. Opioid Treatments for Chronic Pain Research Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/opioid-treatments-chronic-pain-protocol.pdf
     December 19, 2018 - Objectives for the Systematic Review Chronic pain, often defined as pain lasting longer than 3 to 6 months … ), intermediate-term follow-up (6 to 12 months), and long-term follow-up (at least 1 year)? … ), intermediate-term follow-up (6 to 12 months), and long- term follow-up (at least 1 year)? … Results will be stratified according to short-term (1 to 6 months), intermediate term (6 to 12 months … Results will be stratified according to short-term (1 to 6 months), intermediate term (6 to 12 months

146. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1406.pdf
     June 01, 2014 - depending on expert comments received on interventions issued for comment during the preceding 6 months … Mean symptom improvement of all patients who reported outcomes was nearly 60% at 24 months after …  Improved physician global assessment of 51% and 53% from baseline at 6 and 12 months, respectively … cartilage thickness at seven standardized points of 0.4 mm and 0.8 mm from baseline to 6 months and … Followup evaluation was performed at 3 weeks, 3 months, and 6 months by a blinded, independent observer

147. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/depression-postpartum-screening_research-protocol.pdf
     May 01, 2013 - of postpartum onset) will remain unchanged, although the window for diagnosis may be extended to 6 months … .2 Other diagnostic standards allow the definition of onset to extend beyond 4 weeks and up to 12 months … for by bereavement, that is, after the loss of a loved one, the symptoms persist for longer than 2 months … Incidence estimates for the first 3 postpartum months were up to 6.5 percent for major depression alone … Maternal depressive symptoms at 2 to 4 months post partum and early parenting practices.

148. Chronic-Urinary-Retention Research (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-urinary-retention_research.pdf
     September 01, 2014 - All trials measured outcomes at 6 to 7.5 months. … Efficacy of sacral nerve stimulation for urinary retention: results 18 months after implantation. … Schelin, et al., report that after 3 months, the mean IPSS score in the microwave therapy group was … At 6 months, these scores were 7.3 and 4.1, respectively.3 This difference did not reach statistical … Efficacy of sacral nerve stimulation for urinary retention: results 18 months after implantation.

149. Untitled (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism-medical-update_research-protocol.pdf
     February 16, 2016 - c)   What are the longer-term effects (>6 months) on core symptoms (e.g., social deficits, communication … d)   What are the longer-term effects (>6 months) on commonly associated symptoms (e.g., motor, medical … d)   What are the longer-term effects (>6 months) on commonly associated symptoms (e.g., motor, medical … We define short-term outcomes as those measured ≤ 6 months post- treatment and long-term outcomes as … those measured >6 months post-treatment.

150. Urinary-Incontinence-Treatment Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/urinary-incontinence-treatment_surveillance.pdf
     October 29, 2012 - onabotulinumtoxinA Reduction from baseline in the number of UUI episodes per day at 6 months: 3.4 … : 50 U; 100 U; 150 U; Placebo 15.8%; 55%; 50% ;10.7%; p<0.001 Complete continence at 5 months … Placebo (n=2; dose: single injection) 6 months OnabotulinumtoxinA vs. … : 50 U; 100 U; 150 U; Placebo 15.8%; 55%; 50% ;10.7%; p<0.001 Complete continence at 5 months … APFMT at 3 months: 23.28 ± 1.79 vs. 21.80 ± 1.50; p=NS OR= 1.3;,95% CI=0.8, 3.6 Vanessa S.

151. Breast-Cancer-Imaging Technical-Brief (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-cancer-imaging_technical-brief.pdf
     October 01, 2014 - were associated with progression-free survival, but changes seen on bone scans at 6 months were not … conventional imaging FDG uptake correlated with conventional imaging response 14.5 months 27 … ; CT predictive at 6 months Progressive/ non progressive disease using CT or bone scan not … predictive of overall survival at 3 or 6 months 26.7 months Single institution United States … partial response; 71 months stable disease; 52 months progressive disease group (NSD) 4 years

152. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/vaccine-safety_research-protocol.pdf
     September 18, 2012 - – 6 years Hepatitis A 12 months and older http://www.effectivehealthcare.ahrq.gov/ Source: … HPV (human papillomavirus) 9 years – 26 years Influenza (inactivated) 6 months and older Influenza … ) 6 weeks – 18 years Pneumococcal polysaccharide vaccine 2 years and older Rotavirus 6 weeks – 8 months … Tdap (tetanus, diphtheria, and acellular pertussis) 7 years and older Varicella 12 months and … National, state, and local area vaccination coverage among children aged 19–35 months—United States,

153. Traumatic Brain Injury and Depression (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-brain-injury_executive.pdf
     April 01, 2011 - Based on structured clinical interviews, on average 27 percent met criteria for depression 3 to 6 months … from injury; 32 percent at 6 to 12 months; and 33 percent beyond 12 months. … Among the psychiatric conditions examined, anxiety was most common at both study entry and at 12 months … The role of injury severity in neurobehavioral outcome 3 months after traumatic brain injury. … Posttraumatic stress disorder symptoms during the first six months after traumatic brain injury.

154. Executive Summary: Digestible Carbohydrate Intake and Maternal-Infant Outcomes (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/carbohydrate-intake-executive-summary.pdf
     May 01, 2025 - linking digestible carbohydrate intake and outcomes of pregnancy and infancy from birth up to 24 months … digestible carbohydrate intake and infant growth parameters, size, and body composition from birth up to 24 months … association of different amounts of digestible carbohydrate consumed by infants from birth up to 24 months … digestible carbohydrate intake during infancy and growth parameters and body composition up to 24 months

155. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_research-protocol.pdf
     March 09, 2010 - • Oligoarthritis: affects up to four joints within the first 6 months of the illness; may be persistent … • Polyarthritis: affects five or more joints during the first 6 months of disease; is subclassified … • Timing: KQ1-KQ4 • All studies must be at least 3 months in duration. … • Study duration is at least 3 months (KQ1-KQ4). … • Study duration is at least 3 months (KQ1-KQ4).

156. S149 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s149.pdf
     October 01, 2007 - We chose these dates for our baseline analyses so that we would have all data from the first 6 months … we created 19 variables for each patient representing total health care charges for each of the 19 months … the patient would have an indicator signifying that he or she had the medication in the subsequent 2 months … These results suggest that if patients consistently took oral medications for 6 months, exenatide for … 6 months, or insulin for 6 months, the monthly total health care charges of those in the oral medication

157. Evidence Summary Comparative Effectiveness Review No. 250: Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-other-plant-based-treatments-evidence-summary_0.pdf
     October 01, 2021 - controlled) of patients with chronic (mainly neuropathic) pain with short-term treatment (4 weeks to <6 months … 2 Background and Purpose Chronic pain is defined as pain lasting longer than 3 to 6 months … : Benefits of cannabinoids for chronic pain compared with placebo in the short term (4 weeks to <6 months … Question 2: Harms of cannabinoids for chronic pain compared with placebo in the short term (4 weeks to <6 months … In the short term (4 weeks to <6 months), small magnitude improvements in pain severity and overall

158. Executive Summary: Comparative Effectiveness Review No. 256_Effectiveness of Telehealth for Women's Preventive Services (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-256-telehealth-women-preventive-services-executive-summary.pdf
     June 01, 2022 - comparators for contraceptive use (oral contraception, condoms, or long-acting reversible contraception) at 6 months … followup as needed 2 RCTs (1,724) Similar rates of OCP continuation and condom use at 3,6, and 12 months … ; similar rates of LARC use at 6 months.

159. Research White Paper: Outcome Measure Harmonization and Data Infrastructure for Patient-Centered Outcomes Research in Depression (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/white-paper-outcome-measure-harmonization-depression.pdf
     November 01, 2020 - Timeframe for measurement: • 6 months (+/- 60 days) • 12 months (+/- 60 days) In some implementations … Timeframe for measurement: • 6 months (+/- 60 days) • 12 months (+/- 60 days) In some implementations … and an initial PHQ-9* > 9 who demonstrates remission (defined as a PHQ-9 score < 5) of at least 2 months … Timeframe for measurement: • 6 months (+/- 60 days) • 12 months (+/- 60 days) In some implementations … the PRIME Registry and PsychPRO to calculate the harmonized outcome measures was completed in 10 months

160. Engaging-Caregivers-Appendix-B (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/engaging-caregivers-appendix-b.xlsx
     May 29, 2025 - better satisfaction) MICU: 87 vs. 90 CICU: 92 vs. 90 Referrals to post-ICU recovery clinic (mean; 4 months … post intervention vs. 4 months pre intervention) 8.8 per month vs. 5 referrals per month NR NR Support … Usual care (4 months directly preceding implementation period) (n=171) English; Spanish No - created … Duration: NR Followup: 4 month (post-intervention period during same months as preintervention period